About Elloria
Elloria is a company based in Tel Aviv (Israel) founded in 2010 by Michael Epstein, Arnon Epstein, and Simon Dotan. It operates as a B2B. Elloria operates in a competitive market with competitors including Candesant, Sebacia, PhotoSonix Medical, Luma Therapeutics and Nano Ceuticals, among others.
- Headquarter Tel Aviv, Israel
- Founders Michael Epstein, Arnon Epstein, Simon Dotan
- SectorsHealthcare
- Website elloria.com
- Latest Funding Round$1.2M (USD), Grant
Oct 2013
Funding Insights of Elloria
- Total Rounds 1
- Last Round Grant — $1.2M
- First Round $1.2M
(Oct 2013)
All 1 funding rounds of Elloria with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2013 | $1.2M | Grant | – | – | – |
People of Elloria
3 people are tracked at Elloria (3 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Epstein | Co-Founder, CSO | Leadership |
Arnon Epstein | Co-Founder, CEO | Leadership |
Simon Dotan | Co-Founder, COO | Leadership |
Complete people profiles for Elloria
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Elloria
2 dated milestones of Elloria across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Elloria is founded.
- Funding First funding round of $1.2M.
Competitors of Elloria
Elloria operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Candesant, Sebacia, PhotoSonix Medical, Luma Therapeutics and Nano Ceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| candesant.com | 2016 | San Francisco, United States | $44.49M | 3 | Non-invasive energy device for hyperhidrosis treatment is provided. | |
| sebacia.com | 2010 | Duluth, United States | $72.73M | 14 | Develops topical microparticle therapies for dermatological conditions. | |
| photosonixmed.com | 2014 | Ambler, United States | $2.39M | – | Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections | |
| lumatherapeutics.com | 2013 | Millbrae, United States | $2.05M | – | Offers coal tar and light combination therapy for effective psoriasis treatment. | |
| nanoceuticals.net | 2018 | Goiania, Brazil | – | – | Nanoparticle-based products for cosmetics and health sectors are developed. | |
| alvalux.com | 2015 | Liege, Belgium | – | 1 | Develops innovative medical devices focused on scar therapy solutions. | |
| tinyfateraser.com | 2019 | United States | – | – | Sells devices for fat reduction, body shaping, and skin firming online. | |
| binom-physio.ru | 2017 | Kaluga, Russia | – | – | Offers ultrasound and laser therapy devices for medical and therapeutic applications. |
Detailed competitors of Elloria
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Elloria
10 companies that operate in the same segment as Elloria (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elloria
Elloria was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Elloria is headquartered in Tel Aviv, Israel.
Arnon Epstein is the current CEO of Elloria. They have also founded this company.
Elloria provides aesthetic medical devices for hair removal treatments through providing healthcare solutions, developing medical devices, aesthetic treatments, and hair removal. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Elloria's top competitors include Candesant, PhotoSonix Medical and Nano Ceuticals.